Parallax Volatility Advisers
CVS icon

Parallax Volatility Advisers’s CVS Health CVS Stock Holding History

Parallax Volatility Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Sell
30,300
-62,100
-67% -$4.78M 0.01% 753
2025
Q4 		$7.33M Sell
92,400
-95,100
-51% -$7.5M 0.01% 556
2025
Q3 		$14.1M Sell
187,500
-26,000
-12% -$1.78M 0.02% 367
2025
Q2 		$14.7M Sell
213,500
-76,800
-26% -$5.04M 0.03% 334
2025
Q1 		$19.7M Sell
290,300
-301,900
-51% -$18.1M 0.05% 273
2024
Q4 		$26.6M Buy
592,200
+465,400
+367% +$26.1M 0.05% 292
2024
Q3 		$7.97M Sell
126,800
-269,900
-68% -$15.7M 0.01% 631
2024
Q2 		$23.4M Buy
396,700
+328,600
+483% +$20.6M 0.05% 266
2024
Q1 		$5.43M Buy
68,100
+800
+1% +$61.1K 0.01% 709
2023
Q4 		$5.31M Sell
67,300
-600
-0.9% -$42.7K 0.01% 813
2023
Q3 		$4.74M Sell
67,900
-212,000
-76% -$15M 0.01% 783
2023
Q2 		$19.3M Sell
279,900
-45,700
-14% -$3.25M 0.04% 355
2023
Q1 		$24.2M Buy
325,600
+5,600
+2% +$470K 0.05% 339
2022
Q4 		$29.8M Buy
320,000
+136,100
+74% +$13.1M 0.05% 403
2022
Q3 		$17.5M Sell
183,900
-4,500
-2% -$445K 0.03% 548
2022
Q2 		$17.5M Sell
188,400
-69,900
-27% -$6.82M 0.02% 522
2022
Q1 		$26.1M Buy
+258,300
New +$27.1M 0.01% 419
2020
Q4 		– Sell
-1,294,000
Closed -$75.6M – 2715
2020
Q3 		$75.6M Sell
1,294,000
-300,200
-19% -$18.7M 0.06% 291
2020
Q2 		$104M Buy
1,594,200
+191,200
+14% +$12M 0.12% 137
2020
Q1 		$83.2M Buy
1,403,000
+495,700
+55% +$33.1M 0.11% 138
2019
Q4 		$67.4M Buy
907,300
+237,800
+36% +$16.7M 0.08% 178
2019
Q3 		$42.2M Buy
669,500
+187,100
+39% +$11.1M 0.05% 215
2019
Q2 		$26.3M Sell
482,400
-226,200
-32% -$12.2M 0.03% 280
2019
Q1 		$38.2M Buy
708,600
+515,800
+268% +$31.8M 0.04% 208
2018
Q4 		$12.6M Buy
192,800
+55,100
+40% +$4.11M 0.02% 455
2018
Q3 		$10.8M Sell
137,700
-30,700
-18% -$2.19M 0.01% 445
2018
Q2 		$10.8M Sell
168,400
-62,600
-27% -$4.13M 0.02% 408
2018
Q1 		$14.4M Sell
231,000
-281,900
-55% -$20.2M 0.02% 309
2017
Q4 		$37.2M Buy
512,900
+158,900
+45% +$11.6M 0.05% 175
2017
Q3 		$28.8M Sell
354,000
-509,400
-59% -$40.3M 0.05% 203
2017
Q2 		$69.5M Sell
863,400
-2,376,100
-73% -$188M 0.13% 103
2017
Q1 		$254M Buy
3,239,500
+1,641,800
+103% +$131M 0.52% 21
2016
Q4 		$126M Buy
1,597,700
+1,554,700
+3,616% +$126M 0.25% 62
2016
Q3 		$3.83M Buy
43,000
+24,000
+126% +$2.27M 0.01% 779
2016
Q2 		$1.82M Sell
19,000
-184,700
-91% -$18.4M ﹤0.01% 967
2016
Q1 		$21.1M Sell
203,700
-313,700
-61% -$30.5M 0.05% 237
2015
Q4 		$50.6M Sell
517,400
-90,900
-15% -$8.9M 0.1% 127
2015
Q3 		$58.7M Buy
608,300
+528,600
+663% +$55.6M 0.13% 115
2015
Q2 		$8.36M Buy
79,700
+30,400
+62% +$3.11M 0.02% 543
2015
Q1 		$5.09M Sell
49,300
-68,300
-58% -$6.91M 0.01% 701
2014
Q4 		$11.3M Buy
117,600
+81,800
+228% +$7.21M 0.03% 433
2014
Q3 		$2.85M Sell
35,800
-22,100
-38% -$1.74M 0.01% 959
2014
Q2 		$4.36M Buy
57,900
+50,800
+715% +$3.84M 0.02% 525
2014
Q1 		$531K Sell
7,100
-38,700
-84% -$2.73M ﹤0.01% 1002
2013
Q4 		$3.28M Sell
45,800
-26,200
-36% -$1.68M 0.02% 538
2013
Q3 		$4.09M Sell
72,000
-73,900
-51% -$4.4M 0.02% 409
2013
Q2 		$8.34M Buy
+145,900
New +$8.45M 0.04% 317

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parallax Volatility Advisers's CVS Position: Q1 2026 in Review

Parallax Volatility Advisers increased its CVS Health (CVS) stake by 1,675% in Q1 2026, buying an estimated $8.14M and bringing the position to 112,013 shares worth $8.67M. The position accounts for 0.02% of the portfolio, ranked #446.

Parallax Volatility Advisers first reported a position in CVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $43.7M in Q1 2020. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Parallax Volatility Advisers held 112,013 shares of CVS Health worth $8.67M as of Q1 2026.
  • Parallax Volatility Advisers bought 105,704 CVS Health shares in Q1 2026, an estimated $8.14M.
  • CVS Health made up 0.02% of Parallax Volatility Advisers's portfolio in Q1 2026, its #446 holding.
  • Parallax Volatility Advisers first reported a position in CVS Health in Q2 2013 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's CVS Health position peaked at $43.7M in Q1 2020.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.